Title | OCT2 pre-positioning facilitates cell fate transition and chromatin architecture changes in humoral immunity. |
Publication Type | Journal Article |
Year of Publication | 2021 |
Authors | Doane AS, Chu C-S, Di Giammartino DCampigli, Rivas MA, Hellmuth JC, Jiang Y, Yusufova N, Alonso A, Roeder RG, Apostolou E, Melnick AM, Elemento O |
Journal | Nat Immunol |
Volume | 22 |
Issue | 10 |
Pagination | 1327-1340 |
Date Published | 2021 Oct |
ISSN | 1529-2916 |
Keywords | Animals, B-Lymphocytes, Cell Differentiation, Chromatin, Epigenomics, Female, Genomics, Germinal Center, Immunity, Humoral, Male, Mice, Mice, Inbred C57BL, Organic Cation Transporter 2, Protein Domains, Transcription Factors |
Abstract | During the germinal center (GC) reaction, B cells undergo profound transcriptional, epigenetic and genomic architectural changes. How such changes are established remains unknown. Mapping chromatin accessibility during the humoral immune response, we show that OCT2 was the dominant transcription factor linked to differential accessibility of GC regulatory elements. Silent chromatin regions destined to become GC-specific super-enhancers (SEs) contained pre-positioned OCT2-binding sites in naive B cells (NBs). These preloaded SE 'seeds' featured spatial clustering of regulatory elements enriched in OCT2 DNA-binding motifs that became heavily loaded with OCT2 and its GC-specific coactivator OCAB in GC B cells (GCBs). SEs with high abundance of pre-positioned OCT2 binding preferentially formed long-range chromatin contacts in GCs, to support expression of GC-specifying factors. Gain in accessibility and architectural interactivity of these regions were dependent on recruitment of OCAB. Pre-positioning key regulators at SEs may represent a broadly used strategy for facilitating rapid cell fate transitions. |
DOI | 10.1038/s41590-021-01025-w |
Alternate Journal | Nat Immunol |
PubMed ID | 34556886 |
PubMed Central ID | PMC9829245 |
Grant List | R01 CA178765 / CA / NCI NIH HHS / United States R01 AI148387 / AI / NIAID NIH HHS / United States R01 CA194547 / CA / NCI NIH HHS / United States F31 CA220981 / CA / NCI NIH HHS / United States UL1 TR002384 / TR / NCATS NIH HHS / United States R35 CA220499 / CA / NCI NIH HHS / United States P01 CA229086 / CA / NCI NIH HHS / United States |